Phase 2 Ulcerative Colitis (UC) Clinical Trials
13 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–13 of 13 trials
Recruiting
Phase 2
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC)Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe
Eli Lilly and Company1,431 enrolled251 locationsNCT07415044
Recruiting
Phase 1Phase 2
A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC)
Mage Biologics100 enrolled1 locationNCT07374471
Recruiting
Phase 1Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ulcerative Colitis (UC)
Xencor, Inc.270 enrolled52 locationsNCT06619990
Recruiting
Phase 2
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
Ulcerative Colitis (UC)
Northwestern University180 enrolled1 locationNCT07427017
Recruiting
Phase 2
Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease
Crohn DiseaseUlcerative Colitis (UC)IBD
Assistance Publique - Hôpitaux de Paris45 enrolled1 locationNCT07300553
Recruiting
Phase 2
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Crohn's DiseaseUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)
Mirador Therapeutics, Inc.140 enrolled66 locationsNCT07113522
Recruiting
Phase 2
A Study for HSK47388 in Participants With Ulcerative Colitis
Ulcerative Colitis (UC)
Haisco Pharmaceutical Group Co., Ltd.150 enrolled1 locationNCT07335055
Recruiting
Phase 2
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC)UC - Ulcerative Colitis
Odyssey Therapeutics57 enrolled32 locationsNCT06850727
Recruiting
Phase 2
Desloratadine in Patients With Ulcerative Colitis
Ulcerative ColitisUlcerative Colitis (UC)
Tanta University44 enrolled1 locationNCT07333716
Recruiting
Phase 2
Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis
Ulcerative Colitis (UC)
Biocad198 enrolled20 locationsNCT07080034
Recruiting
Phase 1Phase 2
Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease
Ulcerative Colitis (UC)Crohn Disease (CD)
University Medical Center Groningen18 enrolled1 locationNCT06606808
Recruiting
Phase 2
FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients
IBD (Inflammatory Bowel Disease)Ulcerative Colitis (UC)Crohn Disease (CD)
Dalia Lartey20 enrolled1 locationNCT06604260
Recruiting
Phase 2Phase 3
Unravelling Intestinal Fibrosis in Ulcerative Colitis
Fibroblast Activation Protein InhibitorUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10 enrolled1 locationNCT06604273